Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Medis Pharma Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (40)
ARTG (3)
Prescription medicine registration (1)

Date

(-) 2017 (44)
2026 (8)
2025 (58)
2024 (1215)
2023 (3)
2022 (29)
2021 (106)
2020 (31)
2019 (6)
2018 (3)
2015 (2)
2014 (4)
2013 (2)
2012 (7)
2011 (6)
2010 (1)
2009 (1)

Search

Filters applied:

2017

Clear all

Sponsor content

44 result(s) found, displaying 1 to 10

TEVA-EVEROLIMUS everolimus 2.5 mg tablet blister pack (277301)

20 April 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for TEVA-EVEROLIMUS everolimus 2.5 mg tablet blister pack.
TEVA-EVEROLIMUS everolimus 5 mg tablet blister pack (277302)

20 April 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for TEVA-EVEROLIMUS everolimus 5 mg tablet blister pack.
TEVA-EVEROLIMUS everolimus 10 mg tablet blister pack (277304)

20 April 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for TEVA-EVEROLIMUS everolimus 10 mg tablet blister pack.
CAMDIS, AMLODIPINE/ATORVASTATIN-AS, AMLODIPINE/ATORVASTATIN-GX, AMLODIPINE/ATORVASTATIN-MEDIS, AMLODIPINE/ATORVASTATIN-ZP (Medis Pharma Pty Ltd)

12 July 2017

Prescription medicine registration

Active ingredients: amlodipine(as besilate); atorvastatin(as calcium).
PRAVASTATIN ASCENT pravastatin sodium 10 mg tablet blister pack Cancelled under s30(1)(c)

29 June 2017

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
PRAVASTATIN ASCENT pravastatin sodium 20 mg tablet blister pack Cancelled under s30(1)(c)

29 June 2017

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
PRAVASTATIN ASCENT pravastatin sodium 40 mg tablet blister pack Cancelled under s30(1)(c)

29 June 2017

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
GEMCITABINE ACTAVIS 1000 gemcitabine 1000 mg (as hydrochloride) powder for injection vial Cancelled under s30(1)(c)

29 June 2017

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
PANTOPRAZOLE ACTAVIS pantoprazole 40 mg (as sodium sesquihydrate) enteric-coated tablet bottle Cancelled under s30(1)(c)

29 June 2017

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
PRAVAT 20 pravastatin sodium 20 mg tablet blister pack Cancelled under s30(1)(c)

29 June 2017

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd

Pages

Current page 1
Page 2
Page 3
Page 4
Page 5
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.